-- Obalon Therapeutics (NASDAQ: OBLN) reported a net loss of $0.61 per share for the third quarter of 2019, vs. $2.14 per
Obalon Therapeutics (NASDAQ: OBLN): Q3 2019 Earnings Snapshot
Categories
Health Care
Cardinal Health (CAH): Q1 2020 Earnings Snapshot
-- Cardinal Health (NYSE: CAH) reported first-quarter 2020 earnings of $1.27 per share, vs. $1.09 per share expected. -- Total revenue rose
Teva Q3 profit misses estimates, tightens FY19 forecast
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) reported a wider loss in the third quarter of 2019 as generic competition hurt Copaxone revenue
Zoetis (ZTS): Q3 2019 Earnings Snapshot
-- Zoetis Inc. (NYSE: ZTS) reported Q3 2019 earnings of $0.94 per share, vs. $0.88 expected. -- Revenues grew 7% to $1.6
MannKind (NASDAQ: MNKD): Q3 2019 Earnings Snapshot
-- MannKind Corporation (NASDAQ: MNKD) reported a third-quarter 2019 loss of $0.05 per share versus a loss of $0.08 per share expected.
CVS Health Corporation builds on its strong growth in Q3
Building on the strong momentum it has been displaying since the beginning of this year, CVS Health Corporation (NYSE: CVS) on Wednesday
Humana Inc (HUM): Q3 2019 Earnings Snapshot
-- Humana Inc. (NYSE: HUM) reported third-quarter 2019 earnings of $5.03 per share, vs. $4.58 per share expected. -- Total revenue rose
Perrigo Company (PRGO): Q3 2019 Earnings Snapshot
-- Perrigo Company plc (NYSE: PRGO) reported Q3 2019 earnings of $1.04 per share, vs. $0.93 expected. -- Sales grew 5.1% to
Cara Therapeutics’ (CARA) loss expands in Q3 on higher costs
Cara Therapeutics' (NASDAQ: CARA) loss widened in the third quarter of 2019, hurt by higher expenses. Cara Therapeutics posted a loss of
Viking Therapeutics (VKTX): Q3 2019 Earnings Snapshot
-- Viking Therapeutics Inc. (NASDAQ: VKTX) reported Q3 2019 loss of $0.08 per share, vs. a loss of $0.13 expected. -- Net
Allergan (NYSE: AGN) Q3 loss widens but beats estimates
Allergan plc (NYSE: AGN) reported a wider loss in the third quarter of 2019 due to the divestitures, products that lost or
Intercept Pharmaceuticals posts Q3 miss, stock slips
Intercept Pharmaceuticals (NASDAQ: ICPT) on Tuesday reported third-quarter results that missed Wall Street expectations, but raised its guidance for the full year.
Mylan (MYL) Q3 earnings surpass estimates; revenues miss
Drugmaker Mylan (NASDAQ: MYL) reported third-quarter revenues that fell short of expectations. Meanwhile, earnings increased and surpassed the consensus estimate. The company
Regeneron Pharmaceuticals (NASDAQ: REGN): Q3 2019 Earnings Snapshot
-- Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third-quarter 2019 adjusted earnings of $6.67 per share versus $6.36 per share expected. --
Endo International (ENDP): Q3 2019 Earnings Snapshot
-- Endo International plc (NASDAQ: ENDP) reported Q3 2019 earnings of $0.60 per share, vs. $0.53 expected. -- Revenues fell 2% to
Mallinckrodt plc (MNK): Q3 2019 Earnings Snapshot
-- Mallinckrodt plc (NYSE: MNK) reported third-quarter 2019 earnings of $2.07 per share, vs. $1.97 per share expected. -- Revenue fell 7%
Amarin’s Q3 results top estimates
Amarin Corporation plc (NASDAQ: AMRN) reported better-than-expected revenue and earnings for the third quarter of 2019, allowing the stock to gain 2%
Allscripts (NASDAQ: MDRX): Q3 2019 Earnings Snapshot
-- Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) reported its third-quarter 2019 adjusted earnings of $0.17 per share and GAAP loss of $0.03
Bausch Health beats Q3 estimates; raises full-year guidance
Bausch Health Companies Inc. (NYSE: BHC) beat revenue and earnings expectations for the third quarter of 2019, allowing the shares to gain
Allergan (AGN) Q3 earnings preview: Patent issues, AbbVie deal in focus
After securing shareholders' approval for the takeover deal with AbbVie (ABBV), Allergan (NYSE: AGN) will be publishing its third-quarter results on November
Immunogen Inc (NASDAQ:IMGN) Q3 2019 Earnings Call Transcript
Immunogen Inc (IMGN) Q3 2019 earnings call dated Nov 1, 2019 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor Relations